The Weekly Roundup: August 22-26

ICYMI, this week we had stories about adherence issues in acne treatment, shin guard dermatitis, atopic dermatitis in skin of color patients, clinical trial news from Arcutis Biotherapeutics, and more.

POLL: How Many Gen Z Adults Believe SPF 30 Offers 2x the Protection as SPF 15?

Click here to answer this week's poll.

The Mainstream Patient: August 22

This week's edition of the Mainstream Patient features stories about psoriasis in skin of color, the best facial cleansing brushes, a new acne-focused skin care line, Joe Jonas' experience with injectables, and more.

Adherence Issues in the Treatment of Acne

Joshua Zeichner, MD, and Mona Gohara, MD, discuss how adherence becomes an issue in the treatment of acne and what factors lead to lack of adherence in patients.

Skin Barrier and Its Importance in Acne

Joshua Zeichner, MD, and Mona Gohara, MD, discuss the importance of the skin barrier and its importance in acne treatment.

Novavax COVID-19 Vaccine, Adjuvanted, Receives FDA Emergency Use Approval for Patients 12 Years and Older

Emergency Use Authorization provides a 2-dose primary series given 3 weeks apart.

Will Kirby, DO, FAOCD, Interviews Nurse Practitioner Sarah Higgins on Aesthetic Dermatology

Sarah Higgins, DNP, APRN, WHNP-BC, discusses the best career advice she ever got, what she believes is the biggest myth in the aesthetic industry, and what changes she would like to see take place in the field of aesthetic dermatology.

Clinical Presentations of Pediatric AD and Shin Guard Dermatitis

Peter Lio, MD, clinical professor of dermatology and pediatrics at Northwestern University Feinberg School of Medicine in Chicago, Illinois, discusses how atopic dermatitis presents differently in pediatric patients, and the 2021 allergen of the year, acetophenone azine associated with shin guard dermatitis.

Federal Officials Roll Out Plan for Monkeypox Vaccine Production

Domestic production to begin at Michigan-based pharmaceutical maker.

AD Patient Case: FST III

Three dermatologists discuss the case of an 18-year-old patient with AD who is exploring nonsteroidal options to manage his disease.

Gaps in Management of AD SOC Patients

Drs Angela Lamb, Omar Noor, and Neal Bhatia share what they consider to be the biggest gaps in care for patients with SOC: patient/provider education, building trust, and appropriate diagnosis of AD.

Pointers with Dr Portela: Hyperpigmentation

In this week’s Pointers with Dr Portela, the 208SkinDoc gives his skin discoloration treatment tips.

Talking to Children and Adolescents About Vitiligo

Frank discussions about managing the disorder can boost patients’ self-esteem and quality of life.

Skin of Color Society Summit: An Overview

Hiring investigators of color, educating and building trust with potential participants, and addressing funding can make clinical trials more diverse.

Arcutis Finalizes Enrollment in Pivotal Phase 3 Trial of Roflumilast Cream for AD

INTEGUMENT-1 and 2 trial data for atopic dermatitis are expected at the end of 2022.

Feds Warn About Social Engineering in Cyberattacks on Physicians’ Practices

HHS agency warns “vishing,” combining scam emails and phone calls, is on the rise.